Health Care & Life Sciences » Pharmaceuticals | Tonghua Golden-Horse Pharmaceutical Industry Co. Ltd.

Tonghua Golden-Horse Pharmaceutical Industry Co. Ltd. | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
146
207
196
832
1,491
2,071
Cost of Goods Sold (COGS) incl. D&A
81
88
104
283
350
371
Gross Income
65
119
91
549
1,141
1,700
SG&A Expense
86
119
110
324
858
1,445
EBIT
23
2
20
223
282
257
Non Operating Income/Expense
23
13
24
29
10
184
Interest Expense
3
5
2
19
29
43
Pretax Income
3
7
4
246
298
409
Income Tax
1
4
1
36
43
80
Equity in Affiliates
2
2
2
1
2
-
Consolidated Net Income
4
5
7
212
257
329
Net Income
4
5
7
213
258
331
Net Income After Extraordinaries
4
5
7
213
258
331
Net Income Available to Common
4
5
7
213
258
331
EPS (Basic)
0.01
0.01
0.01
0.23
0.27
0.34
Basic Shares Outstanding
449
449
686
928
966
966
EPS (Diluted)
0.01
0.01
0.01
0.23
0.27
0.34
Diluted Shares Outstanding
449
449
686
928
966
966
EBITDA
7
13
5
273
343
326
Other Operating Expense
2
2
2
3
1
2
Non-Operating Interest Income
-
-
2
6
35
12
Minority Interest Expense
-
-
-
2
1
2

About Tonghua Golden-Horse Pharmaceutical Industry Co.

View Profile
Address
No. 999 Jinma Road
Tonghua Jilin 134003
China
Employees -
Website http://www.thjm.cn
Updated 07/08/2019
Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products. It specializes in traditional Chinese medicine, western medicine, and exclusive variety. Its products are used for anti-tumor, microbial, digestive system, skeletal muscle system, gynecological, and nervous system multiple fields.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.